Novatrials is now running a clinical study of a potential new treatment aimed at alleviating the symptoms of hyperuricemia. If you suffer with hyperuricemia or high serum uric acid, you may be eligible to participate.
The trial involves up to 13 visits over a 6 week period and participants receive a reimbursement for travel to attend the Charlestown in-clinic visits.
